Conference Coverage

Dilara Kiran, DVM, MS, shares practical ways veterinary professionals can begin engaging in policy, from the AVMA Congressional Advocacy Network to advocacy days and state veterinary medical associations.

Dilara Kiran, DVM, MS, maps 2 ways vets shape policy: applying science to inform decisions, and crafting practice rules on issues ranging from vaccines to telemedicine.

Anita Patel, DVM, shares why the spectrum of care was one of her key takeaways from AVMA Convention sessions and discusses how veterinarians can use available tools and resources to provide care that considers both patient needs and client circumstances.

Anita Patel, DVM, discusses why acknowledging uncertainty, welcoming feedback, and leading with vulnerability can help veterinary leaders build trust, strengthen accountability, and encourage team members to contribute new ideas.

From the fear of diabetic ketoacidosis to the real cost of monitoring, Ellen Behrend, VMD, MS, PhD, DACVIM (SAIM), makes the case that SGLT2 inhibitors are safer and easier to use in cats with diabetes than many practitioners assume, and explains who the right candidate is.

Dilara Kiran, DVM, MS, explains why policy engagement extends beyond the federal government and highlights New World screwworm as an example of why proactive regulations matter.

Dilara Kiran, DVM, MS, shares why veterinarians are uniquely positioned to contribute to policy, highlighting how everyday clinical decision-making translates to stakeholder engagement and advocacy.

Anita Patel, DVM, explains why transparency, constructive feedback, and solution-oriented thinking can help veterinary teams influence organizational decisions and improve practice operations.

Drawing on insights shared by federal officials at the USDA, FDA, and CDC during a joint session at the 2026 AVMA Convention, along with the latest federal guidance, agency data, and published resources, this report explains what veterinarians need to know about the flesh-eating parasite.

With complication risk rising as anesthetic time increases, Rebecca A. Johnson, DVM, PhD, DACVAA, outlined practical steps to reduce perianesthetic risk in brachycephalic patients through careful planning, airway management, and recovery protocols during a 2026 AVMA Convention session.

Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), explains which feline patients may benefit from SGLT2 inhibitors, outlines key contraindications, and discusses the evolving conversation around cats with ketones.

Anita Patel, DVM, senior director of clinical excellence at IndeVets, discusses the challenges of navigating organizational change, from aligning values and goals to supporting teams through periods of transition.

Dilara Kiran, DVM, MS, explains why policy engagement extends beyond federal government, highlighting opportunities for veterinary professionals to influence decisions within their practices, communities, and the broader profession, in this interview from the 2026 AVMA Convention.

Disney's vice president of Animals, Science and Environment made the case that the best animal care happens with animals, not to them, and that no one achieves it alone.

Do feline diabetes diets need to change when a cat starts an SGLT2 inhibitor? Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), discusses what veterinarians should consider when balancing dietary recommendations, gastrointestinal adverse effects, and DKA concerns.

Concerns about diabetic ketoacidosis, ketone monitoring, and cost may prevent some veterinarians from considering SGLT2 for cats with diabetes. Ellen Behrend, VMD, PhD, MS, DACVIM (SAIM), discusses what monitoring is needed and how reduced monitoring requirements may help make these medications more affordable for owners.

At the 2026 AVMA Convention, Will P. Rausch, DVM, DACVIM (Cardiology), discussed where NT-proBNP fits in feline cardiomyopathy screening and why the test should be used as part of a broader diagnostic approach.

More than 700 continuing-education sessions run across 5 days, July 10–14. Here are the ones to circle first, sorted by practice area, plus a handful that are easy to scroll past and worth catching.

A comparison of the 2025 and 2026 AVMA Convention programs reveals a growing focus on affordability and access, alongside increased programming on New World screwworm, disaster preparedness, and veterinary practice ownership.

Take a closer look at one of the most overlooked aspects of a practice transition in this episode of The Vet Blast Podcast, presented by dvm360.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, cVMA, explains intravenous regional limb perfusion in a dvm360 interview.

dvm360's annual conference in Missouri introduces the 2026 Veterinary Heroes and features unique opportunities to network and learn

Hosted by the North American Veterinary Community, the annual Veterinary Meeting & Expo will offer more than 1000 hours of continuing education.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, explains how transdermal drug delivery is administered and processed by various animal species, in a dvm360 interview.

Jessie Ziegler, DVM, MS, DACVIM (LAIM), discusses a key point of her recent lecture at the 2026 ACVIM Forum.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, cVMA, explains what makes alternative drug delivery unique vs standard drug delivery.

Results of a study on a GLP-1 therapy in development were presented during the 2026 ACVIM Forum.

The American College of Veterinary Internal Medicine (ACVIM) recognized 15 investigators at the 2026 ACVIM Forum in Seattle, Washington.